Bradley Cooper unveils his latest directorial venture 'Is This Thing On?' at the New York Film Festival, sharing his deep connection to the city and the comedy scene. With Arnett and Dern on board, the film promises to be a heartfelt exploration of friendship and catharsis.
A humorous and profound letter to Tilly Norwood, exploring the nuances of acting, human connection, and the challenges of growing up in a world filled with superficiality. This heartfelt advice encapsulates the essence of being an actress.
Zach Bryan faces backlash over his upcoming song 'Bad News,' criticized for allegedly attacking ICE and President Trump. The country star insists it's a love song for America amidst growing division.
A woman who survived a tragic church shooting in Michigan shares her powerful story of forgiveness towards the gunman who killed her father, highlighting a message of love over hate in the face of tragedy.
Discover the horrifying tale of Kenneth McDuff, the Texas serial killer who escaped justice, along with chilling stories of unsolved mysteries and tragic deaths in this week's macabre newsletter.
Tom Brady defends his dual role as Fox's lead analyst and minority owner of the Raiders amid concerns of a conflict of interest. He emphasizes his ethical duty to the sport in his latest newsletter.
Join a vibrant community of tech and business enthusiasts! Engage in discussions, access exclusive news, and catch up on insights from global leaders in finance and media.
In a passionate defense of Jimmy Kimmel, Stephen Colbert denounces censorship after ABC suspends Kimmel's show amid political backlash. Fellow comedians like David Letterman join the fight for free speech.
House Oversight Chairman James Comer dismisses calls for a handwriting expert to analyze Trump's alleged signature on Epstein's birthday letter, insisting it has no relevance to the ongoing investigation into Epstein's financial records.
In a bold move, the Trump administration is sending out 100 cease-and-desist letters to drug companies, aiming to eliminate misleading ads. This crackdown includes increased transparency about drug risks and closing loopholes that conceal vital safety information.
